<div dir="ltr"><div dir="ltr"><div dir="ltr"><div dir="ltr"><div dir="ltr"><div dir="ltr"><div dir="ltr"><div class="gmail_default" style="font-family:georgia,serif">Hi Andreas,</div><div class="gmail_default" style="font-family:georgia,serif"><br></div><div class="gmail_default" style="font-family:georgia,serif">I am interested in possible joint research work, my students are working in the area of CML, </div><div class="gmail_default" style="font-family:georgia,serif"><br></div><ol><li><div class="gmail_default" style="font-family:georgia,serif"><p style="text-align:left;color:rgb(0,0,0);text-transform:none;text-indent:0px;letter-spacing:normal;font-family:Times New Roman;font-size:16px;font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;word-spacing:0px;white-space:normal">A Novel Philadelphia-positive chromosome with trisomy 48XY, t(9;22) (q34;q11), +19,+der(22)t and a common 47 XY, trisomy 8 case with chronic myelogenous Leukemia ( Submitted)<br></p></div></li><li><div class="gmail_default" style="font-family:georgia,serif"><a class="gmail-gsc_a_at" style="padding:8px 0px;text-align:left;color:rgb(102,0,153);text-transform:none;text-indent:0px;letter-spacing:normal;font-family:Arial,sans-serif;font-style:normal;font-variant:normal;font-weight:400;text-decoration:underline;word-spacing:0px;white-space:normal">A rare case of three-way complex variant translocation in chronic myeloid leukemia t (6; 9; 22)(p21; q34; q11): A case report</a></div></li><li><div class="gmail_default" style="font-family:georgia,serif"><a class="gmail-gsc_a_at" style="padding:8px 0px;text-align:left;color:rgb(102,0,153);text-transform:none;text-indent:0px;letter-spacing:normal;font-family:Arial,sans-serif;font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;word-spacing:0px;white-space:normal">A Novel four-way complex variant translocation involving chromosome 46, XY, t (4; 9; 19; 22)(q25: q34; p13. 3; q11. 2) in a chronic myeloid leukemia patient</a></div></li><li><div class="gmail_default" style="font-family:georgia,serif"><a class="gmail-gsc_a_at" style="padding:8px 0px;text-align:left;color:rgb(102,0,153);text-transform:none;text-indent:0px;letter-spacing:normal;font-family:Arial,sans-serif;font-style:normal;font-variant:normal;font-weight:400;text-decoration:underline;word-spacing:0px;white-space:normal">A rare case of a three way complex variant positive Philadelphia translocation involving chromosome (9; 11; 22)(q34; p15; q11) in chronic myeloid leukemia: A case report</a></div></li><li><div class="gmail_default" style="font-family:georgia,serif"><a class="gmail-gsc_a_at" style="padding:8px 0px;text-align:left;color:rgb(102,0,153);text-transform:none;text-indent:0px;letter-spacing:normal;font-family:Arial,sans-serif;font-style:normal;font-variant:normal;font-weight:400;text-decoration:underline;word-spacing:0px;white-space:normal">Three-way complex variant translocation involving short arm chromosome (1; 9; 22)(p36; q34; q11) in a chronic myeloid leukemia patient</a></div></li><li><div class="gmail_default" style="font-family:georgia,serif"><a class="gmail-gsc_a_at" style="padding:8px 0px;text-align:left;color:rgb(102,0,153);text-transform:none;text-indent:0px;letter-spacing:normal;font-family:Arial,sans-serif;font-style:normal;font-variant:normal;font-weight:400;text-decoration:underline;word-spacing:0px;white-space:normal">Assessment of circulating biochemical markers and antioxidative status in acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) patients</a></div></li></ol><div><div class="gmail_default" style="font-family:georgia,serif">I am interested in Joint research work. </div><br></div><div class="gmail_signature" dir="ltr"><div dir="ltr"><div dir="ltr"><div dir="ltr"><p style="margin:0px;color:rgb(0,0,255);font-family:"Comic Sans MS";font-size:small"><font color="#2672ec" style="font-family:Calibri,sans-serif;font-size:16px">Abrar Hussain</font><span style="color:rgb(0,0,0);font-family:Calibri,sans-serif;font-size:16px"> </span><font color="#008a17" size="1" style="font-family:Calibri,sans-serif">B.Sc, LLB, M.Sc, MS, PhD</font><br style="color:rgb(0,0,0);font-family:Calibri,sans-serif;font-size:16px"><font color="#2672ec" style="font-family:Calibri,sans-serif;font-size:16px">Professor</font></p><div style="color:rgb(0,0,0);font-family:Calibri,sans-serif;font-size:16px"><font color="#2672ec"><font size="1">****************************************************************************</font><br></font><font size="1">BUITEMS, Quetta, Pakistan.<br><font color="#2672ec">Mobile:</font> + 92 321 80 11 571.<br><font color="#2672ec">Email:</font><a href="mailto:abrarbangash176@hotmail.com" target="_blank">abrarbangash176@hotmail.com</a>,<a href="mailto:abrarbangash176@gmail.com" target="_blank">abrarbangash176@gmail.com</a>, <br><font color="#2672ec">Skype</font>: abrarhkhan :: <font color="#2672ec">Scopus ID</font>:36659278000 :: <font color="#2672ec">ORCID</font> :<a href="http://orcid.org/0000-0002-7646-5643" target="_blank">http://orcid.org/0000-0002-7646-5643</a><br><font color="#2672ec">ResearcherID</font>:J-1334-2014, <a href="http://www.researcherid.com/rid/J-1334-2014" target="_blank">http://www.researcherid.com/rid/J-1334-2014</a><br><font color="#2672ec">Research Gate</font>: <a href="https://www.researchgate.net/profile/Abrar_Hussain6/contributions" target="_blank">https://www.researchgate.net/profile/Abrar_Hussain6/contributions</a><br><font color="#2672ec">Google Scholar:</font> <a href="http://scholar.google.com.pk/citations?user=YOYAGP0AAAAJ&hl=en" target="_blank">http://scholar.google.com.pk/citations?user=YOYAGP0AAAAJ&hl=en</a><br><font color="#2672ec">Linkedin: </font> <a href="http://www.linkedin.com/pub/abrar-hussain/92/2b/947" target="_blank">http://www.linkedin.com/pub/abrar-hussain/92/2b/947</a></font></div></div></div></div></div><br></div></div></div></div></div></div></div><br><div class="gmail_quote"><div dir="ltr">On Sun, Oct 14, 2018 at 5:24 PM Andreas Lennartsson <<a href="mailto:andreas.lennartsson@ki.se">andreas.lennartsson@ki.se</a>> wrote:<br></div><blockquote class="gmail_quote" style="margin:0 0 0 .8ex;border-left:1px #ccc solid;padding-left:1ex">
<div style="word-wrap:break-word;line-break:after-white-space">
<div style="direction:ltr;font-family:Tahoma;color:#000000;font-size:10pt">Dear all
<div>I am looking for a post-doc for bioinformatic analysis of AML. Please share the add if you know a suitable candidate.<br>
<div><a href="https://ki.mynetworkglobal.com/en/what:job/jobID:230930/type:job/where:4/apply:1" rel="noopener noreferrer" style="font-family:Calibri,sans-serif;font-size:15px" target="_blank">https://ki.mynetworkglobal.com/en/what:job/jobID:230930/type:job/where:4/apply:1</a><br>
<div><br>
<div style="font-family:Tahoma;font-size:13px">Thanks for you help!</div>
<div style="font-family:Tahoma;font-size:13px"><br>
</div>
<div style="font-family:Tahoma;font-size:13px">best regards</div>
<div style="font-family:Tahoma;font-size:13px">/Andreas</div>
<div style="font-family:Tahoma;font-size:13px"><br>
</div>
<div style="font-family:Tahoma;font-size:13px"><b><br>
</b></div>
<div style="font-family:Tahoma"><font size="1"><b>Andreas Lennartsson, PhD</b> </font>
<div><font size="1">Associate Prof</font></div>
<div><font size="1">Karolinska Institutet</font></div>
<div><font size="1">Department of Biosciences and Nutrition</font></div>
<div><font size="1">Hälsovägen 7</font></div>
<div><font size="1">SE-14183 Huddinge, Sweden</font></div>
<div>
<div><b><br>
</b></div>
</div>
</div>
</div>
<div style="font-family:Times New Roman;color:#000000;font-size:16px">
<div><br>
</div>
</div>
</div>
</div>
</div>
</div>
_______________________________________________<br>
SocBiN mailing list<br>
<a href="mailto:SocBiN@lists.su.se" target="_blank">SocBiN@lists.su.se</a><br>
<a href="https://lists.su.se/mailman/listinfo/socbin-at-sbc.su.se" rel="noreferrer" target="_blank">https://lists.su.se/mailman/listinfo/socbin-at-sbc.su.se</a><br>
</blockquote></div>